In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4697-4706

  Fayolle, Catherine ^a   Sebo, Peter ^a,b   Ladant, Daniel ^a   Ullmann, Agnes ^a   Leclerc, Claude ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CD8 ANTIGEN; PERTUSSIS VACCINE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BORDETELLA PERTUSSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; PERTUSSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; BORDETELLA PERTUSSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; H-2 ANTIGENS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0030002543     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563.
2. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
3. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
4. Carbone, F. R., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377.
5. Pincus, S., J. Tartaglia, and E. Paoletti. 1995. Poxvirus-based vectors as vaccine candidates. Biologicals 23:159.
6. + cytotoxic T cells. J. Exp. Med. 72:1083.
7. Aldovini, A., and R. A. Young. 1991. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351:479.
8. Winter, N., M. Lagranderie, S. Gangloff, C. Leclerc, M. Gheorghiu, and B. Gicquel. 1995. Recombinant BCG strains expressing the SIVmac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13:471.
9. Shen, H., M. K. Slifka, M. Matloubian, E. R. Jensen, and R. Ahmed. 1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. USA 92: 3987.
10. + T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int. Immunol. 7:797.
11. Hanski, E. 1989. Invasive adenylate cyclase toxin of Bordelella pertussis. Trends Biochem. Sci. 14:459.
12. Gordon, V. M., W. W. Young, Jr., S. M. Lechler, M. C. Gray, S. H. Leppla, and E. L. Hewlett. 1989. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis: different processes for interaction with and entry into target cells. J. Biol. Chem. 264:14792.
13. Mock, M., and A. Ullmann. 1993. Calmodulin-activated bacterial adenylate cyclases as virulence factors. Trends Microbiol. 1:187.
14. Ladant, D., P. Glaser, and A. Ullmann. 1992. Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J. Biol. Chem. 267:2244.
15. + cytotoxic T-cells. Infect. Immun. 63:3851.
16. Aichele, P., H. Hengartner, R. M. Zinkernagel, and M. Schulz. 1990. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171:1815.
17. Zhou, X., U. M. Abdel Motal, L. Berg, and M. Jondal. 1992. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur. J. Immunol. 22:3085.
18. Takahashi, H., R. N. Germain, B. Moss, and J. A. Berzofsky. 1990. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J. Exp. Med. 171:571.
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Betsou, F., P. Sebo, and N. Guiso. 1993. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect. Immun. 61:3583.
21. Sebo, P., P. Glaser, H. Sakamoto, and A. Ullmann. 1991. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system. Gene 104:19.
22. Bellalou, J., H. Sakamoto, D. Ladant, C. Geoffroy, and A. Ullmann. 1990. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect. Immun. 58:3242.
23. + T cell help. J. Immunol. 147:4069.
24. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loker, M. Pierres, and F. W. Fitch. 1984. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1-5: similarity of L3T4 to human Leu3/4 molecule. J. Immunol. 131:2445.
25. Pierres, M., C. Goridis, and P. Goldstein. 1982. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94,000 and 180,000 molecular weight. Eur. J. Immunol. 12:60.
26. Gilboa-Ron, A., A. Rogel, and E. Hanski. 1989. Bordetella pertussis adenylate cyclase inactivation by the host cell. Biochem. J. 262:25.
27. Donnelly, J. J., J. B. Ulmer, L. A. Hawe, A. Friedman, X. P. Shi, K. R. Leander, J. W. Shiver, A. I. Oliff, D. Martinez, D. Montgomery, and M. A. Liu. 1993. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 90:3530.
28. Ke, Y., Y. Li, and J. A. Kapp. 1995. Ovalbumir injected with complete Freund's adjuvant stimulates cytolytic responses. Eur. J. Immunol. 25:549.
29. + cytotoxic cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344:873.
30. Raychaudhuri, S., M. Tonks, F. Carbone, T. Ryskamp, W. J. W. Morrow, and N. Hanna. 1992. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc. Natl. Acad. Sci. USA 89:8308.
31. Wizel, B., W. O. Rogers, R. A. Houghten, D. E. Lanar, J. A. Tine, and S. T. Hoffman. 1994. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Eur. J. Immunol. 24:1487.
32. Walker, C., M. Selby, A. Erickson, D. Cataldo, J. P. Valensi, and G. Van Nest. 1992. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Proc. Natl. Acad. Sci USA 89:7915.
33. Schirmbeck, R., W. Böhm, and J. Reimann. 1994. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur. J. Immunol. 24:2068.
34. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 153:2554.
35. Bachmann, M. F., T. M. Kündig, G. Freer, Y. Li, C. Y. Kang, D. H. Bishop, H. Hentgartner, and R. M. Zinkernagel. 1994. Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immunol. 24:2128.
36. Rock, K. L., L. Rothstein, S. Gamble, and C. Fleischacker. 1993. Characterization of antigen-presenting cells that present exogenous antigens in association with class 1 MHC molecules. J. Immunol 150:438.
37. Kovacsovics-Bankowski, M., and K. L. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243.
38. Adams, S. E. 1993. Induction of humoral and cellular immunity by recombinant, particulate antigen presentation systems. Vaccine Res. 2:163.
39. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1110.
40. Dillon, S. B., S. G. Demuth, M. A. Schneider, C. B. Weston, C. S. Jones, J. F. Young, M. Scott, P. K. Bhatnaghar, S. LoCastro, and N. Hanna. 1992. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxyde adjuvant. Vaccine 10:309.
41. Gao, X.-M., B. Zheng, F. Y. Liew, S. Brett, and J. Tite. 1991. Priming of influenza virus-specific cytotoxic T lymphocytes in vivo by short synthetic peptides. J. Immunol. 147:3268.